biotech
Bio-AnalystResearch Platform
person
arrow_backExplore/Chromium
Public-ready7/3/2026

Chromium

Papers analyzed
86
Glucose and metabolic health markersBlood pressure and vascular health markersStress Response and Sleep Changes
What to look for in this research

Glucose and metabolic health markers is closer to a research marker, so it should be read separately from a directly felt benefit.

Main benefit evidence

Review human evidence by goal.

Glucose and metabolic health
Glucose and metabolic health markers
Measured outcomes: Glucose and metabolic markers

This card is closer to a measured biomarker or lab outcome than a directly felt user benefit. These findings come from a defined study population, so everyday effects may differ.

Goal tierNot rated yet

Direct evidence for general supplement use is currently limited under this standard.

2 human studies in a specific clinical context are available separately.

Check this goal in more detail
Blood pressure and vascular health
Blood pressure and vascular health markers
Measured outcomes: Blood pressure and vascular markers

This card is closer to a measured biomarker or lab outcome than a directly felt user benefit. These findings come from a defined study population, so everyday effects may differ.

Goal tierNot rated yet

The currently linked research coverage is not broad enough to characterize this goal yet.

Check this goal in more detail
Stress and mood
Stress Response and Sleep Changes
Measured outcomes: Stress and mood balance

These findings come from stress response, cortisol, anxiety, or sleep outcomes. They may mix felt benefits with physiological markers.

Goal tierNot rated yet

The currently linked research coverage is not broad enough to characterize this goal yet.

Check this goal in more detail
Blood lipids
Cholesterol and triglycerides
Measured outcomes: Cholesterol and triglycerides

Potential benefit studied in Blood lipids. These findings come from a defined study population, so everyday effects may differ.

Goal tierNot rated yet

No direct evidence for general supplement use is confirmed under the current standard.

Check this goal in more detail
Women's health
Menstrual and women's health
Measured outcomes: Menstrual and women's health

Potential benefit studied in Women's health. These findings come from a defined study population, so everyday effects may differ.

Goal tierNot rated yet

The currently linked research coverage is not broad enough to characterize this goal yet.

Check this goal in more detail
Nutrient status and deficiency
Blood-Level or Deficiency Marker
Measured outcomes: Blood level or deficiency correction markers

This is based on lab markers such as blood levels, deficiency correction, or absorption. Read it separately from directly felt outcomes.

Goal tierNot rated yet

The currently linked research coverage is not broad enough to characterize this goal yet.

Check this goal in more detail

What does a research result actually tell you?

Reading research

Side effects and combination findings in studies

Findings from studies of this ingredient alone are separated from findings involving another supplement or medication.

Caution signals
4
Side effects + combos + curated rules
Key precautions
No curated contraindication rule is available yet, but literature caution signals are shown below.
These are signals reported in studies. They do not predict what will happen to an individual.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported when this ingredient was used alone

Symptoms or adverse events reported in studies of this ingredient without another active ingredient.

Adverse effect signal1 papers
Animal models exposed to chromium picolinate experienced degenerative changes in spermatogenesis.Animal studies · Study type not identified
Adverse effect signal1 papers
Literature data pinpoints mechanisms of oxidative stress induced by chromium compounds in somatic and germ cells that lead to apoptosis, underlining the impairment of fertility potential.Cell studies · Study type not identified
DNA damage1 papers
In db/db mice, prolonged treatment with high doses of chromium-picolinate resulted in high variability of DNA damage and dosage-dependent suppression of detoxification pathways, indicating potential individual toxicity risks.Animal studies · Study type not identified
Adverse effect signal1 papers
In a double-blind placebo-controlled trial, non-obese normoglycemic subjects receiving chromium picolinate 500 μg twice daily for 16 weeks showed no improvement in insulin sensitivity, and those with the highest serum chromium levels paradoxically experienced a decline in insulin sensitivity.Human studies · Study type not identified
Chromium
arrow_backBack to list